Association of the metabolic syndrome with age-related, nonatherosclerotic, chronic medical conditions

Metabolic Syndrome and Related Disorders

Volumn 9, Issue 5, 2011, Pages 327-335

  Barzilay, Joshua I ^a   Stein, Phyllis K ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

AGING; ALBUMINURIA; ATHEROSCLEROSIS; AUTONOMIC DYSFUNCTION; AUTONOMIC NEUROPATHY; CARDIOVASCULAR DISEASE; CIRCADIAN RHYTHM; COGNITIVE DEFECT; DIABETES MELLITUS; DISEASE ASSOCIATION; EXHAUSTION; FRAIL ELDERLY; GLUCOSE HOMEOSTASIS; GRIP STRENGTH; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LEAN BODY WEIGHT; LIFESTYLE MODIFICATION; METABOLIC SYNDROME X; OBESITY; OSTEOPOROSIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TELOMERE; WALKING SPEED; WEAKNESS; WEIGHT REDUCTION;

ADIPOSITY; AGE FACTORS; AGED; AGING; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; CIRCADIAN RHYTHM; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; OSTEOPOROSIS;

EID: 80053548481     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2011.0027     Document Type: Review

References (86)

1. Meigs JB. Invited commentary: Insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol 2000;152:908-911.
2. Sakkinen PA, Wahl P, Cushman M, Lewis MR, Tracy RP. Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am J Epidemiol 2000;152:897-907.
3. Haffner SM. The metabolic syndrome: Inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol 2006;97:3A-11A. (Pubitemid 43139714)
4. McNeill AM, Katz R, Girman CJ, Rosamond WD, Wagenknecht LE, Barzilay JI, Tracy RP, Savage PJ, Jackson SA. Metabolic syndrome and cardiovascular disease in the elderly. The Cardiovascular Health Study. J Am Geriatr Soc 2006;54:1317-1324.
5. Ginsburg HN, MacCallum PR. The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part 1. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus. J Cardiometab Syndr 2009;4:113-119.
6. Fried LP, Xue QL, Cappola AR, Ferrucci L, Chaves P, Varadhan R, Guralnik JM, Leng SX, Semba RD, Walston JD, Blaum CS, Bandeen-Roche K. Nonlinear multisystem physiological dysregulation associated with frailty in older women: Implications for etiology and treatment. J Gerontol A Biol Sci Med Sci 2009;64:1049-1057.
7. Bortz WM II. A conceptual framework for frailty: A review. J Gerontol A Biol Sci Med Sci 2002;57:M283-M288.
8. Walston J, McBurnie MA, Newman A, Tracy RP, Kop WJ, Hirsch CH, Gottdiener J, Fried LP. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities. Results from the Cardiovascular Health Study. Arch Intern Med 2002; 162: 2333-2341. (Pubitemid 35332516)
9. Barzilay JI, Blaum C, Moore T, Xue QL, Hirsch CH, Walston JD, Fried LP. Insulin resistance and inflammation as precursors of frailty: The Cardiovascular Health Study. Arch Intern Med 2007;167:635-641. (Pubitemid 46598454)
10. Degens H. The role of systemic inflammation in age-related muscle weakness and wasting. Scand J Med Sci Sports 2010; 20:28-38.
11. Gelfand RA, Barrett EJ. Effect of physiologic hyperinsulinemia on skeletal muscle protein synthesis and breakdown in man. J Clin Invest 1987;80:1-6. (Pubitemid 17097508)
12. Abbatecola AM, Ferrucci L, Ceda G, Russo CR, Lauretani F, Bandinelli S, Barbieri M, Valenti G, Paolisso G. Insulin resistance and muscle strength in older persons. J Gerontol A Biol Sci Med Sci 2005;60:1278-1282. (Pubitemid 41612420)
13. Barzilay JI, Cotsonis GA, Walston J, Schwartz AV, Satterfield S, Miljkovic I, Harris T. Insulin resistance is associated with decreased quadriceps muscle strength in non-diabetic adults, age > 70 years. Diabetes Care 2009;32:736-738.
14. Diabetes Prevention Program Research Group, Crandall J, Schade D, Ma Y, Fujimoto WY, Barrett-Connor E, Fowler S, Dagogo-Jack S, Andres R. The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes. J Gerontol A Biol Sci Med Sci 2006;61:1075-1081. (Pubitemid 44727217)
15. Lanza IR, Short DK, Short KR, Rakhavakaimal S, Basu R, Joyner MJ, McConnell JP, Nair KS. Endurance training as a countermeasure for aging. Diabetes 2008;57:2933-2942.
16. Cukierman T, Gerstein HC, Williamson JD. Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies. Diabetologia 2005;48:2460-2469. (Pubitemid 41738208)
17. Euser SM, Sattar N, Witteman JC, Bollen EL, Sijbrands EJ, Hofman A, Perry IJ, Breteler MM, Westendorp RG; PROSPER and Rotterdam Study. A prospective analysis of elevated fasting glucose levels and cognitive function in older people: Results from PROSPER and the Rotterdam Study. Diabetes 2010;59:1601-1607.
18. Williamson JD, Miller ME, Bryan RN, Lazar RM, Coker LH, Johnson J, Cukierman T, Horowitz KR, Murray A, Launer LJ; ACCORD Study Group. The action to control cardiovascular risk in diabetes memory in diabetes study (ACCORDMIND): rationale, design, and methods. Am J Cardiol 2007;99: S112-S122. (Pubitemid 46961889)
19. Frisardi V, Solfrizzi V, Seripa D, Capurso C, Santamato A, Sancarlo D, Vendemiale G, Pilotto A, Panza F. Metabolic-cognitive syndrome: A cross-talk between metabolic syndrome and Alzheimer's disease. Ageing Res Rev 2010;9:399-417.
20. Ruis C, Biessels GJ, Gorter KJ, van den Donk M, Kappelle LJ, Rutten GE. Cognition in the early stage of type 2 diabetes. Diabetes Care 2009;32:1261-1265.
21. Dik MG, Jonker C, Comijs HC, Deeg DJ, Kok A, Yaffe K, Penninx BW. Contribution of metabolic syndrome components to cognition in older individuals. Diabetes Care 2007;30:2655-2660. (Pubitemid 47547816)
22. Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI, Tylavsky FA, Newman AB. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004;292:2237-2242. (Pubitemid 39473161)
23. Komulainen P, Lakka TA, Kivipelto M, Hassinen M, Helkala EL, Haapala I, Nissinen A, Rauramaa R. Metabolic syndrome and cognitive function: A population-based follow-up study in elderly women. Dement Geriatr Cogn Disord 2007;23:29-34. (Pubitemid 46005788)
24. Raffaitin C, Gin H, Empana JP, Helmer C, Berr C, Tzourio C, Portet F, Dartigues JF, Alpérovitch A, Barberger-Gateau P. Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: The Three-City Study. Diabetes Care 2009;32:169-174.
25. Vanhanen M, Koivisto K, Moilanen L, Helkala EL, Hänninen T, Soininen H, Kervinen K, Kesä niemi YA, Laakso M, Kuusisto J. Association of metabolic syndrome with Alzheimer disease: A population-based study. Neurology 2006;67: 843-847. (Pubitemid 44394200)
26. Laudisio A, Marzetti E, Pagano F, Cocchi A, Franceschi C, Bernabei R, Zuccalà G. Association of metabolic syndrome with cognitive function: The role of sex and age. Clin Nutr 2008;27:747-754.
27. Muller M, Tang MX, Schupf N, Manly JJ, Mayeux R, Luchsinger JA. Metabolic syndrome and dementia risk in a multiethnic elderly cohort. Dement Geriatr Cogn Disord 2007;24:185-192. (Pubitemid 47312668)
28. Forti P, Pisacane N, Rietti E, Lucicesare A, Olivelli V, Mariani E, Mecocci P, Ravaglia G. Metabolic syndrome and risk of dementia in older adults. J Am Geriatr Soc 2010;58: 487-492.
29. Cavalieri M, Ropele S, Petrovic K, Pluta-Fuerst A, Homayoon N, Enzinger C, Grazer A, Katschnig P, Schwingenschuh P, Berghold A, Schmidt R. Metabolic syndrome, brain magnetic resonance imaging, and cognition. Diabetes Care 2010;33:2489-2495.
30. Dik MG, Jonker C, Comijs HC, Deeg DJ, Kok A, Yaffe K, Penninx BW. Contribution of metabolic syndrome components to cognition in older individuals. Diabetes Care 2007;30:2655-2660. (Pubitemid 47547816)
31. Roberts RO, Geda YE, Knopman DS, Cha RH, Boeve BF, Ivnik RJ, Pankratz VS, Tangalos EG, Petersen RC. Metabolic syndrome, inflammation, and non-amnestic mild cognitive impairment in older persons: A population-based study. Alzheimer Dis Assoc Disord 2010;24:11-18.
32. Solfrizzi V, Scafato E, Capurso C, D'Introno A, Colacicco AM, Frisardi V, Vendemiale G, Baldereschi M, Crepaldi G, Di Carlo A, Galluzzo L, Gandin C, Inzitari D, Maggi S, Capurso A, Panza F; Italian Longitudinal Study on Ageing Working Group. Metabolic syndrome and the risk of vascular dementia: The Italian Longitudinal Study on Ageing. J Neurol Neurosurg Psychiatry 2010;81:433-440.
33. Abbatecola AM, Paolisso G, Lamponi M, Bandinelli S, Lauretani F, Launer L, Ferrucci L. Insulin resistance and executive dysfunction in older persons. J Am Geriatr Soc 2004;52:1713-1718. (Pubitemid 41709926)
34. van Oijen M, Okereke OI, Kang JH, Pollak MN, Hu FB, Hankinson SE, Grodstein F. Fasting insulin levels and cognitive decline in older women without diabetes. Neuroepidemiology 2008;30:174-179. (Pubitemid 351667798)
35. Schuur M, Henneman P, van Swieten JC, Zillikens MC, de Koning I, Janssens AC, Witteman JC, Aulchenko YS, Frants RR, Oostra BA, van Dijk KW, van Duijn CM. Insulin-resistance and metabolic syndrome are related to executive function in women in a large family-based study. Eur J Epidemiol 2010; 25:561-568.
36. Rasgon NL, Kenna HA, Wroolie TE, Kelley R, Silverman D, Brooks J, Williams KE, Powers BN, Hallmayer J, Reiss A. Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease. Neurobiol Aging 2009;Dec 24. [Epub ahead of print].
37. Tournoy J, Lee DM, Pendleton N, O'Neill TW, O'Connor DB, Bartfai G, Casaneuva FF, Finn JD, Forti G, Giwercman A, Han TS, Huhtaniemi IT, Kula K, Lean ME, Moseley CM, Punab M, Silman AJ, Vanderschueren D, Wu FC, Boonen S; EMAS Study Group. Association of cognitive performance with the metabolic syndrome and with glycaemia in middle-aged and older European men: The European Male Ageing Study. Diabetes Metab Res Rev 2010; 26: 668-676.
38. Launer LJ, Masaki K, Petrovitch H, Foley D, Havlik RJ. The association between midlife blood pressure levels and latelife cognitive function. The Honolulu-Asia Aging Study. JAMA 1995;274:1846-1851. (Pubitemid 26001260)
39. Duron E, Hanon O. Hypertension, cognitive decline and dementia. Arch Cardiovasc Dis 2008;101:181-189.
40. Milionis HJ, Florentin M, Giannopoulos S. Metabolic syndrome and Alzheimer's disease: A link to a vascular hypothesis? CNS Spectr 2008;13:606-613.
41. Lopez OL, Jagust WJ, Dulberg C, Becker JT, DeKosky ST, Fitzpatrick A, Breitner J, Lyketsos C, Jones B, Kawas C, Carlson M, Kuller LH. Risk factors for mild cognitive im- pairment in the Cardiovascular Health Study Cognition Study: Part 2. Arch Neurol 2003;60:1394-1399. (Pubitemid 37248800)
42. Reitz C, Tang M-X, Manly J, Mayeux J, Luchsinger JA. Hypertension and the risk of mild cognitive impairment. Arch Neurol 2007;64:1734-1740. (Pubitemid 350254935)
43. Barzilay JI, Peterson D, Cushman M, Heckbert SR, Cao JJ, Blaum C, Tracy RP, Klein R, Herrington DM. The relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension: The cardiovascular health study. Am J Kidney Dis 2004;44:25-34. (Pubitemid 38880923)
44. Farkas E, Luiten PGM. Cerebral microvascular pathology in aging and Alzheimer's disease. Prog Neurobiol 2001;64:575-611. (Pubitemid 32304447)
45. Fioretto P, Steffes MW, Brown DM, Mauer SM. An overview of renal pathology in insulin-dependent diabetes mellitus in relationship to altered glomerular hemodynamics. Am J Kidney Dis 1992;20:549-558. (Pubitemid 23031703)
46. Barzilay JI, Fitzpatrick A, Luchsinger J, Yasar S, Bernick C, Jenny NS, Kuller LH. Albuminuria and dementia in the elderly: A community study. Am J Kid Dis 2008;52: 216-226. (Pubitemid 351982029)
47. Barzilay JI, Gao P, O'Donnell M, Mann JFE, Anderson C, Fagard R, Probstfield J, Dagenais GR, Teo K, Yusuf S. Albuminuria and decline in cognitive function: The ONTARGET / TRANSCEND Studies. Arch Intern Med 2011;171:142-150.
48. Garg AX, Kiberd BA, Clark WF, Haynes RB, Clase CM. Albuminuria and renal insufficiency prevalence guides population screening: Results from NHANES III. Kidney Int 2002;61:2165-2175. (Pubitemid 34539334)
49. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 2004;140:167-174.
50. Barzilay JI, Peterson D, Cushman M, Heckbert SR, Cao JJ, Blaum C, Tracy RP, Klein R, Herrington DM. The relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension: The Cardiovascular Health Study. Am J Kid Dis 2004;44:25-34. (Pubitemid 38880923)
51. Mitchell GF. Effects of central arterial aging on the structure and function of the peripheral vaculature; implications for end-organ damage. J Appl Physiol 2008;105:1652-1660.
52. Zipser BD, Johanson CE, Gonzalez L, Berzin TM, Tavares R, Hulette CM, Vitek MP, Hovanesian V, Stopa EG. Microvascular injury and blood-brain barrier leakage in Alzhermer's disease. Neurobiol Aging 2007;28:977-986. (Pubitemid 46635913)
53. Vallon V. The proximal tubule in the pathophysiology of the diabetic kidney. Am J Physiol Regul Integr Comp Physiol 2011;300:R1009-R1022.
54. Park K, Yasuda N, Toyonaga S, Yamada SM, Nakabayashi H, Nakasato M, Nakagomi T, Tsubosaki E, Shimizu K. Significant association between leukoaraiosis and metabolic syndrome in healthy subjects. Neurology 2007;69:974-978. (Pubitemid 47366050)
55. Hollingworth P, Harold D, Sims R, et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nature Genet 2011; doi:10.1038/ng.803
56. Kleiger RE, Stein PK, Bigger JT. Heart rate variability: measurement and clinical utility. Ann Noninvasive Electrocardiol 2005;10:1-14.
57. Stein PK, Barzilay JI. Relationship of abnormal heart rate turbulence and elevated CRP to cardiac mortality in low, intermediate, and high-risk older adults. J Cardiovasc Electrophysiol 2011;22:122-127.
58. Denys K, Cankurtaran M, Janssens W, Petrovic M. Metabolic syndrome in the elderly: An overview of the evidence. Acta Clin Belg 2009;64:23-34.
59. Stein PK, Barzilay JI, Domitrovich PP, Chaves PM, Gottdiener JS, Heckbert SR, Kronmal RA. The relationship of heart rate and heart rate variability to non-diabetic fasting glucose levels and the metabolic syndrome: The Cardiovascular Health Study. Diab Med 2007:24:855-863. (Pubitemid 47093043)
60. Schroeder EB, Chambless LE, Liao D, Prineas RJ, Evans GW, Rosamond WD, Heiss G. Diabetes, glucose, insulin, and heart rate variability: The Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care 2005;28:668-674. (Pubitemid 40315330)
61. Singh JP, Larson MG, O'Donnell CJ, Wilson PF, Tsuji H, Lloyd-Jones DM, Levy D. Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study). Am J Cardiol 2000;86:309-312. (Pubitemid 30462227)
62. Stein PK, Barzilay JI, Chaves PHM, Traber J, Domitrovich PP, Heckbert SR, Gottdiener JS. Inflammation factors and insulin resistance are independently associated with increased heart rate and diminished heart rate variability in normoglycemic older individuals: The Cardiovascular Health Study. J Am Geriat Soc 2008;56:315-321. (Pubitemid 351160704)
63. Liao D, Sloan RP, Cascio WP, Folsom AR, Liese AD, Evans GW. Multiple metabolic syndrome is associated with lower heart rate variability. The Atherosclerosis Risk in Communities Study. Diabetes Care 1998;21:2116-2122.
64. Festa A, D'Agostino R Jr, Hales CN,Mykkänen L, Haffner SM. Heart rate in relation to insulin sensitivity and insulin secretion in nondiabetic subjects. Diabetes Care 2000;23:624-628. (Pubitemid 30321541)
65. Pikkujämsä SM, Huikuri HV, Airaksinen KE, Rantala AO, Kauma H, Lilja M, Savolainen MJ, Kesäniemi YA. Heart rate variability and baroreflex sensitivity in hypertensive subjects with and without metabolic features of insulin resistance syndrome. Am J Hypertens 1998;11:523-531. (Pubitemid 28270712)
66. Scheer FA, Hilton MF, Mantzoros CS, Shea SA. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc Natl Acad Sci USA 2009;106:4453-4458.
67. Lumeng JC, Somashekar D, Appugliese D, Kaciroti N, Corwyn RF, Bradley RH. Shorter sleep duration is associated with increased risk for being overweight at ages 9 to 12 years. Pediatrics 2007;120:1020-1029. (Pubitemid 350085535)
68. Green CB, Takahashi JS, Bass J. The meter of metabolism. Cell 2008;134:728-742.
69. Maury E, Ramsey KM, Bass J. Circadian rhythms and metabolic syndrome. From experimental genetics to human disease. Circ Res 2010;106:447-462.
70. Gibson EM, Williams WP, Kriegsfeld LJ. Aging in the circadian system: Considerations for health, disease prevention, and longevity. Exp Gerontol 2009;44:51-56.
71. Cavadini G, Petrzilka S, Kohler P, Jud C, Tobler I, Birchler T, Fontana A. TNF-alpha suppresses the expression of clock genes by interfering with E-box-mediated transcription. Proc Natl Acad Sci USA 2007;104:12843-12848. (Pubitemid 47255242)
72. Vgontzas AN, Zoumakis E, Lin HM, Bixler EO, Trakada G, Chrousos GP. Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist. J Clin Endocrinol Metab 2004;89:4409-4413. (Pubitemid 39244447)
73. Maemura K, de la Monte SM, Chin MT, Layne MD, Hsieh CM, Yet SF, Perrella MA, Lee ME. CLIF, a novel cycle-like factor, regulates the circadian oscillation of plasminogen activator inhibitor-1 gene expression. J Biol Chem 2000;275: 36847-36851. (Pubitemid 32002096)
74. Duez H, Staels B. Nuclear receptors linking circadian rhythms and cardiometabolic control. Arterioscler Thromb Vasc Biol 2010;30:1529-1534.
75. Stein PK, Barzilay JI. Abnormal heart rate turbulence predicts cardiac mortality in low, intermediate and high risk older adults. J Cardiovasc Electrophysiol 2011;22:122-127.
76. Kleiger RE, Miller JP, Bigger JT, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987;59:256-262. (Pubitemid 17036947)
77. Kinjo M, Setoguchi S, Solomon DH. Bone mineral density in adults with the metabolic syndrome: Analysis of a population- based U.S. sample. J Clin Endocrinol Metab 2007;92:4161-4164. (Pubitemid 350074726)
78. Von Muhlen D, Safii S, Jassal SK, Svartberg J, Barrett-Connor E. Associations between the metabolic syndrome and bone health in older men and women: The Rancho Bernardo Study. Osteoporos Int 2007;18:1337-1344. (Pubitemid 47389466)
79. Yaturu S, Humphrey S, Landry C, Jain SK. Decreased bone mineral density in men with the metabolic syndrome alone and with type 2 diabetes. Med Sci Monitor 2009;15:CR5- CR9.
80. Ahmed LA, Schirmer H, Berntsen GK, Fonnebo, Joakimsen RM. Features of the metabolic syndrome and risk of nonvertebral fractures: The Tromsø Study. Osteoporos Int 2006;17: 426-432.
81. Kim HY, Choe JW, Kim HK, Bae SJ, Kim BJ, Lee SH, Koh JM, Han KO, Park HM, Kim GS. Negative association between metabolic syndrome and bone mineral density in Koreans, especially men. Calcif Tisse Int 2010;86:350-358.
82. Tseng YH, Huang KC, Liu ML, Shu WT, Sheu WH. Association between metabolic syndrome (MS) and bone mineral loss: A cross-sectional study in Puli Township in Taiwan. Arch Gerontol Geriatr 2009;49(Suppl 2):S37-S40.
83. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403. (Pubitemid 34437694)
84. Oeseburg H, de Boer RA, van Gilst WH, van der Harst P. Telomere biology in healthy aging and disease. Pflugers Arch 2010;459:259-268.
85. O'Callaghan NJ, Clifton PM, Noakes M, Fenech M. Weight loss in obese men is associated with increased telomere length and decreased abasic sites in rectal mucosa. Rejuvenation Res 2009;12:169-176.
86. Goldfine AB, Fonseca V, Jablonski KA, Pyle L, Staten MA, Shoelson SE; TINSAL-T2D (Targeting Inflammation Using Salsalate in Type 2 Diabetes) Study Team. The effects of salsalate on glycemic control in patients with type 2 diabetes: A randomized trial. Ann Intern Med 2010;152:346-357.